JTA invests €50M in animal and human serum production

English , International - بین الاقوامی , Snippets , / Wednesday, July 3rd, 2024

Download this post as PDF

JTA International Investment Holding and KZA Medical have forged a partnership to develop a cutting-edge Pharmaceutical production complex in Turkey. The first phase of investment includes the development of a factory dedicated to producing animal and human serums. The €50M agreement, signed in JTA’s office in Qatar and followed promptly by JTA depositing the committed capital, solidifies the collaboration between the two entities aimed at developing one of the largest pharmaceutical complexes in the Middle East.

“With JTA’s investment, we have acquired the project land, started factory construction, and executed the purchase orders for production machinery. We hope to achieve commercial production by mid-2026”, said CEO of KZA Medical.

This investment milestone in the pharmaceutical industry promises advancements in serum production that will benefit both animal and human health sectors. With a focus on innovation and quality, the factory aims to meet growing demands for serums. The partnership between JTA International Investment Holding and KZA Medical underscores a shared commitment to driving progress in healthcare through state-of-the-art manufacturing and ground-breaking research within the region.

“The aim of our partnership is to build a world-class pharmaceutical complex in Turkey. We are committed to follow on investments and hope that our collaboration with KZA transforms into a new era in the pharmaceutical industry”, said CEO of JTA International Investment Holding